Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study.
García Ruiz PJ, Sesar Ignacio A, Ares Pensado B, Castro García A, Alonso Frech F, Alvarez López M, Arbelo González J, Baiges Octavio J, Burguera Hernández JA, Calopa Garriga M, Campos Blanco D, Castaño García B, Carballo Cordero M, Chacón Peña J, Espino Ibáñez A, Gorospe Onisalde A, Giménez-Roldán S, Granés Ibáñez P, Hernández Vara J, Ibáñez Alonso R, Jiménez Jiménez FJ, Krupinski J, Kulisevsky Bojarsky J, Legarda Ramírez I, Lezcano García E, Martínez-Castrillo JC, Mateo González D, Miquel Rodríguez F, Mir P, Muñoz Fargas E, Obeso Inchausti J, Olivares Romero J, Olivé Plana J, Otermin Vallejo P, Pascual Sedano B, Pérez de Colosía Rama V, Pérez López-Fraile I, Planas Comes A, Puente Periz V, Rodríguez Oroz MC, Sevillano García D, Solís Pérez P, Suárez Muñoz J, Vaamonde Gamo J, Valero Merino C, Valldeoriola Serra F, Velázquez Pérez JM, Yáñez Baña R, Zamarbide Capdepon I. García Ruiz PJ, et al. Mov Disord. 2008 Jun 15;23(8):1130-6. doi: 10.1002/mds.22063. Mov Disord. 2008. PMID: 18442107
Epidemiological assessment of levodopa use in Cuba: 1993-1998.
Lara G, Cuadrado-Gamarra JI, de Pedro-Cuesta J, Esteban EM, Giménez-Roldán S, Luis-González S. Lara G, et al. Pharmacoepidemiol Drug Saf. 2006 Jul;15(7):521-6. doi: 10.1002/pds.1150. Pharmacoepidemiol Drug Saf. 2006. PMID: 16200653
Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study.
Fénelon G, Giménez-Roldán S, Montastruc JL, Bermejo F, Durif F, Bourdeix I, Péré JJ, Galiano L, Schadrack J. Fénelon G, et al. J Neural Transm (Vienna). 2003 Mar;110(3):239-51. doi: 10.1007/s00702-002-0799-z. J Neural Transm (Vienna). 2003. PMID: 12658373 Clinical Trial.
[Dopamine agonists situation in Parkinson disease].
Barbanoj M, Campos Arillo VM, Giménez-Roldán S, Kulisevsky J, Linazasoro Cristóbalampos G, Luquin Piudo MR, Vela Desojo L. Barbanoj M, et al. Rev Neurol. 2001 Dec 1-15;33(11):1071-93. Rev Neurol. 2001. PMID: 11785037 Spanish.
176 results